COVID-19 RNA may induce monocytes to develop cancer-fighting properties, potentially shrinking tumors in certain metastatic cancers. Patients resistant to prior immunotherapy showed the most benefit ...

2024 OCT 23 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- Current study results on RNA Viruses - Coronavirus have been published. According to news reporting originating ...

The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended, according to new research from UC San Francisco that offers ...

The COVID-19 virus may have the surprising ability to shrink some tumors, paving the way for new cancer treatments, a new study has found. The research, conducted at the Northwestern Medicine Canning ...

Many of the most devastating infectious diseases are caused by RNA viruses, and Model Medicines is working on one compound to kill them all. The AI drug discoverer’s oral small molecule was able to ...

A preclinical study finds that COVID can trigger the development of an immune cell that can fight cancer The COVID-19 virus may come with a surprising benefit. It may have the ability to shrink ...

In his new book, “The Catalyst,” Dr. Thomas Cech describes how mRNA in the COVID vaccines encodes the virus’s spike protein. The following is an excerpt from The Catalyst: RNA and the Quest to Unlock ...

The COVID-19 virus may come with a surprising benefit. It may have the ability to shrink certain cancerous tumors, according to a new study. The research was conducted at the Northwestern Medicine ...